FDA's Office Of Criminal Investigations May Undergo Overhaul With The Resignation of Its Director
This article was originally published in The Pink Sheet Daily
Terry Vermillion, who has headed up the office for 18 years, resigned two months after a whistleblower complaint about him was made public.
You may also be interested in...
OCI Director John Roth set to depart upon his confirmation to Homeland Security Department post.
Former acting HHS inspector general will become associate commissioner for regulatory affairs two years after Margaret O'Keeffe Glavin's retirement.
FDA Commissioner Margaret Hamburg outlined reforms planned for the agency's Office of Criminal Investigations, including new criteria for selecting misdemeanor prosecution cases against responsible corporate officials